Unlearn AI
What They Do edit
Generates AI digital twins from clinical data to optimize clinical trials. Uses patient longitudinal data for prediction and generates synthetic control arms, reducing trial sizes and timelines.
AIDAVA Relevance edit
Longitudinal patient data for digital twins, synthetic data generation
Funding edit
Valuation: ~$200M+ (est.) $50M+
Business Details edit
- Founded: 2019
- Total Funding: $50M Series C
- Valuation: ~$200M+ (est.)
- Revenue: N/A (private)
- Employees: ~50-100 (est.)
- Key Milestones: $50M Series C. Digital twins for clinical trials. Applied to VectorY PIONEER-ALS study.